Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:7 Number:25 ISSN#:2563-5476
RCT
ACE Report #11898
Ace Report Cover Osteoarthritis

Triamcinolone hexacetonide favoured to botulinum toxin and saline injection for treatment of knee OA


Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A

Comparison between intra-articular Botulinum toxin type A, corticosteroid, and saline in knee osteoarthritis: a randomized controlled trial

Clin Rehabil. 2019 Jun;33(6):1015-1026.

Contributing Authors: A Rosenfeld J Natour JG Mendes JC Nunes-Tamashiro SR Toffolo RNV Furtado

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

105 patients diagnosed with mild-to-moderate knee osteoarthritis were randomized to receive an intra-articular injection of botulinum toxin type A (BTA), triamcinolone hexacetonide (TH) or 0.9% saline. The primary outcome of interest was pain during movement, measured on a Visual Analog Scale (VAS). Secondary outcomes of interest included VAS pain at rest, the Western Ontario and McMaster Universi...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.